Biotechnology company
Issues related to the 340B Drug Discount Program; drug pricing; and general education about policies impacting pharmaceutical development, approval, reimbursement and pricing. Issues related to diversity in clinical trials. The potential inclusion of these and other healthcare policies in reconciliation legislation, "Build Back Better" HR 5376 Funding for flu preparedness and the SNS. Issues related to the 340B Drug Discount Program; drug pricing; and general education about policies impacting pharmaceutical development, approval, reimbursement and pricing. Issues related to diversity in clinical trials. The potential inclusion of these and other healthcare policies in reconciliation legislation.
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
RIVENDELL GROUP LLP
1440 G Street, NW, Washington, DC, 20005, US
MATTHEW BERZOK (LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch) NICK KOLOVOS (LA and Counsel, Rep. Anna Eshoo) MATTHEW BERZOK (LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch) NICK KOLOVOS (LA and Counsel, Rep. Anna Eshoo)
LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch LA and Counsel, Rep. Anna Eshoo LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch LA and Counsel, Rep. Anna Eshoo